Allergy
Conditions
Keywords
heparin, heparin-induced thrombocytopenia, HIT, allergy, skin, dermatology, DTH, delayed-type hypersensitivity, histology, Patients receiving sc heparin therapy, Age over 18 years, Recruitment will stop when 20 patients with skin lesions are included
Brief summary
An increased number of patients with heparin-induced skin lesions is reported in the literature. Heparin-induced skin lesions may result from either occlusion of cutaneous vessels in patients suffering from autoimmune HIT or from a type IV allergic reaction (delayed type hypersensitivity (DTH) response). However, the incidence and nature of heparin-induced skin lesions has not been determined in a prospective investigation. To address this open issue is the goal of this ongoing, so far monocenter, clinical investigation.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* age \> 18 Y. * s.c. anticoagulant therapy \>6 days
Exclusion criteria
* history of HIT * history of DTH to heparin
Countries
Germany